Inhaled aztreonam
O'Sullivan, Brian P. Yasothan, Uma Kirkpatrick, Peter
O'Sullivan, Brian P.
Yasothan, Uma
Kirkpatrick, Peter
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2010-05-01
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
In February 2010, aztreonam for inhalation solution (Cayston; Gilead) - an inhalable formulation of the monobactam antibiotic aztreonam and lysine - was approved by the US FDA to improve respiratory symptoms in patients with cystic fibrosis infected with Pseudomonas aeruginosa.
Source
Nat Rev Drug Discov. 2010 May;9(5):357-8. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1038/nrd3170
Permanent Link to this Item
PubMed ID
20431562